Elevance Health Executives on Medicaid Financial Challenges: 7 Things to Know
Elevance Health recently reported its third-quarter earnings for 2024, highlighting some temporary financial challenges in its Medicaid business. As the company navigates these issues, executives have expressed confidence that they are only short-term hurdles. The financial impact was evident as Elevance cut its earnings outlook for 2024 from $37.20 in net income per diluted share to $33, driven mainly by slimmer margins in its Medicaid operations.
However, CEO Gail Boudreaux assured investors that the company expects a “timing disconnect” between the health needs (acuity) of its Medicaid population and the reimbursement rates set by states, which often use outdated data. Let’s delve into seven key things to know about Elevance Health’s current Medicaid challenges and future outlook.
The Temporary Nature of Financial Challenges in Medicaid Business
Elevance Health, one of the largest health insurers in the United States, is facing a temporary setback in its Medicaid business, primarily due to a decline in membership and rising medical costs. Although these challenges have led to a revision of the company’s earnings outlook for 2024, Elevance executives maintain that these issues are short-lived.
The core problem lies in the “timing disconnect” between state-set payment rates and the actual medical costs of Medicaid beneficiaries. States often use data that is more than a year old to determine Medicaid payment rates, resulting in misaligned reimbursement structures. Despite these hurdles, Elevance Health is optimistic about the long-term profitability of its Medicaid business.
Seven Key Insights on Elevance Health’s Medicaid Challenges
1. Decline in Medicaid Membership
Since the third quarter of 2023, Elevance Health has seen a 20% decline in its Medicaid membership. This trend is part of a broader national decline in Medicaid enrollment, which KFF (Kaiser Family Foundation) reports as a 15% reduction across the country. This decline began when states resumed disenrolling Medicaid beneficiaries, a process that had been halted during the COVID-19 pandemic due to continuous enrollment requirements.
2. Higher Medical Costs in Medicaid
Medical costs in Medicaid have surged to three to five times higher than historical averages, according to Elevance CEO Gail Boudreaux. This spike is attributed to a mismatch between the medical needs of the remaining Medicaid population and the outdated state data used to calculate reimbursement rates. Essentially, states are not adjusting payment rates fast enough to reflect the increased acuity (severity of health conditions) of Medicaid beneficiaries.
3. Industry-Wide Impact of Medicaid Redeterminations
Elevance Health is not the only insurer grappling with the effects of Medicaid redeterminations. UnitedHealth Group CFO John Rex echoed similar concerns, citing a “timing mismatch” between the acuity of the Medicaid population and the reimbursement rates. After redeterminations, the members who remain in the program tend to have more complex medical needs, which drive up costs for insurers.
4. Long-Term Attractiveness of Medicaid Business
Despite the current challenges, Gail Boudreaux emphasized that the shift in Medicaid membership is “unprecedented” but believes the Medicaid business remains attractive in the long run. The company’s strategy involves navigating these short-term hurdles while maintaining a focus on future growth and profitability in this sector.
5. Profitability Expectations for 2024
Elevance CFO Mark Kaye acknowledged that the company’s Medicaid business will remain profitable in 2024, although it will fall below the company’s target margin. The expectation is that the financial challenges are temporary, and the company will eventually meet its profitability goals once state payment rates catch up to the higher medical costs.
6. Increase in Medical Loss Ratio
In the third quarter of 2024, Elevance Health’s medical loss ratio (MLR) rose to 89.5%, a noticeable increase from 86.8% in the same period last year. The medical loss ratio represents the percentage of premium revenue spent on healthcare services. CFO Mark Kaye noted that the MLR will likely be one percentage point higher in 2024 than initially projected due to Medicaid expenses.
7. Medicaid Challenges Are Temporary
Gail Boudreaux reassured investors that the challenges in the Medicaid business are “time-bound.” The company is actively working with state partners on rate renewals, which are expected to eventually align with the medical acuity of its Medicaid population. Although there is a lag in the rate-setting process, Boudreaux remains confident that the underlying financial dynamics will improve.
Conclusion
Elevance Health’s Medicaid challenges are primarily driven by a timing disconnect between state payment rates and the medical needs of its Medicaid population. Although the company has revised its earnings outlook for 2024, Elevance executives maintain that these issues are temporary and that the Medicaid business will return to its expected profitability. As the company works closely with state partners to adjust rates, investors can expect improved financial performance in the coming quarters.
Discover the latest payers’ news updates with a single click. Follow DistilINFO HealthPlan and stay ahead with updates. Join our community today!
FAQs
Q1: Why did Elevance Health cut its earnings outlook for 2024?
A. Elevance Health reduced its earnings outlook for 2024 due to slimmer margins in its Medicaid business, driven by higher medical costs and outdated state payment rates.
Q2: What is causing higher medical costs in Medicaid?
A. Medical costs in Medicaid have surged because the remaining Medicaid members after redeterminations have more complex and severe health needs, leading to higher expenses.
Q3: How much has Elevance Health’s Medicaid membership declined?
A. Elevance Health’s Medicaid membership has dropped by 20% since the third quarter of 2023, in line with national trends caused by the end of continuous enrollment policies.
Q4: Will Elevance Health’s Medicaid business be profitable in 2024?
A. Yes, Elevance Health expects its Medicaid business to remain profitable in 2024, although profitability will be below its target margin.
Q5: What is the medical loss ratio, and why has it increased?
A. The medical loss ratio (MLR) represents the percentage of premium revenue spent on healthcare services. Elevance’s MLR increased to 89.5% due to higher Medicaid costs.
Q6: Are other insurers facing similar Medicaid challenges?
A. Yes, other insurers like UnitedHealth Group have reported similar issues, particularly a timing mismatch between Medicaid members’ acuity and state payment rates.
Q7: How does Elevance Health plan to overcome its Medicaid challenges?
A. Elevance Health is working with state partners on rate renewals and expects payment rates to eventually reflect the medical needs of its Medicaid population.
